Bringing Dark Genome-Targeted Personalized Cancer Vaccines to the Clinic
Time: 11:15 am
day: Day 2
Details:
- A new class of cancer vaccines based on an off-the-shelf antigen-presenting cell line (PDC*line)
- Harnessing the PDC*line Pharma platform to develop effective personalized cancer vaccines (PDC*neo)
- Unlocking the dark genome: discovering novel neoantigen targets for cancer immunotherapy
